Shares of Jaguar Health (JAGX) are currently trading higher in the pre-market, as we recently reported that the company revealed the sale of $6 million in Mytesi royalties to a secured lender last week.
A pharmaceuticals company focused on developing sustainable, novel gastrointestinal products, and Jaguar Health Inc is currently commercial-stage.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Before the market opened today, Jaguar Health’s (JAGX) share was trading at an increased price of $0.833, which was higher by 16.08%. The average volume for the stock during the last three-month period was 30.40 million. However, its shares are trading at a distance of 82.52% from its 20-days Simple Moving Average.